Navigation Links
A Breakthrough for Migraines, PMS and PCOS!
Date:12/23/2010

LOS ANGELES, Dec. 23, 2010 /PRNewswire/ -- In a world where millions suffer daily from the debilitating pain of migraine headaches, one name stands out as the definitive leader in natural, safe and effective treatment.  MigreLief by Akeso Health Sciences.

Now, patients are raving about the amazing results of the new breakthrough product from Akeso.  MigreLief+M (Menstrual) is the first of its kind supplement aimed at preventing migraines and other symptoms associated with a woman's menstrual cycle.

"There is a direct relationship between hormones and headaches," explains Curt Hendrix M.S. C.C.N., C.N.S., scientist and creator of MigreLief+M. "Headaches in women, particularly migraines, have been related to changes in the levels of the female hormones estrogen and progesterone before, during and after a woman's menstrual cycle.  These hormone levels fluctuate dramatically and are associated with a large percentage of migraines in women."

The release of MigreLief+M is life-changing news, not only for migraine sufferers but also for women who experience PMS symptoms such as cravings, breast tenderness, bloating, cramps, depression and irritability.  The active ingredients in this menstrually targeted MigreLief have been shown to not only balance the hormonal fluctuations that lead to menstrual related migraines, but also significantly decrease PMS symptoms as well.

What is the secret to the success of world renowned MigreLief? "The ingredients that are used are continuously monitored for quality and integrity by independent analytical laboratories throughout the manufacturing process. These ingredients are then used in the exact form and dose proven effective in human clinical studies.  Our supplements are of higher quality than those currently on the market because of this exacting scientific attention to purity and potency."

MigreLief+M is no exception and promises to be another winner with a multitude of added benefits:

  • Same reliable migraine treatment as MigreLief original formula with additional compounds to treat Menstrual migraines and alleviate many PMS and PCOS symptoms.
  • May be beneficial in reducing the occurrence of premenstrual acne.
  • Can be taken with your prescription migraine drugs and has no side-effects.
  • Regulates blood sugar balance that is a migraine trigger in many patients.
  • MigreLief Facebook and Twitter interface directly with consumers to support their ongoing health questions and needs.

  • All MigreLief products are available in select pharmacies and online at www.migrelief.com.  For more information and product samples contact sales@akesohealth.com.  

    About Akeso Health SciencesFounded by Curt Hendrix in 1992, Akeso is a family company dedicated to continuing research and breakthrough technologies for the development of patented supplements that have helped tens of thousands find the joy and peace of a new life without migraines.  The company consistently delivers innovative, leading edge solutions for migraineurs worldwide. (www.migrelief.com)Contact:Steve Hendrixsales@akesohealth.com (800) 758-8746DISCLAIMER: MigreLief™ is not intended to diagnose, treat, cure, or prevent any disease or illness.  Frequent use of this product may result in considerable weight loss.  Please consult with your licensed medical practitioner if you have, or suspect you may have, a health problem.


    '/>"/>

    SOURCE Akeso Health Sciences
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Bad Virus Put to Good Use: Breakthrough Batteries
    2. Bridging between Earth and space: technology breakthroughs for scientific progress
    3. Breakthrough in nanocrystals growth
    4. A revolutionary breakthrough in terahertz remote sensing
    5. European Nurse Society Calls to Action on Breakthrough Cancer Pain
    6. Breakthrough e-display means electronics with high speed, high readability and low power usage
    7. Medicago discovers breakthrough method of preparing plant derived recombinant proteins and VLPs and files two PCT patent applications
    8. Deloitte Recap Honors Sanofi-aventis and Exelixis With the Allicense 2010 Breakthrough Alliance Award for Early-Stage Collaboration in Cancer
    9. Breakthrough gene therapy prevents retinal degeneration
    10. New paper offers breakthrough on blinking molecules phenomenon
    11. A revolutionary breakthrough in terahertz remote sensing
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/27/2016)... June 27, 2016  Sequenom, Inc. (NASDAQ: ... healthier lives through the development of innovative products and ... the United States denied its petition ... claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 Patent") ... established by the Supreme Court,s Mayo Collaborative Services v. ...
    (Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
    (Date:6/24/2016)... ... 24, 2016 , ... Researchers at the Universita Politecnica delle Marche in Ancona ... or pleural mesothelioma. Their findings are the subject of a new article on the ... are signposts in the blood, lung fluid or tissue of mesothelioma patients that can ...
    (Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
    Breaking Biology Technology:
    (Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
    (Date:6/16/2016)... 16, 2016 The global ... to reach USD 1.83 billion by 2024, according ... Inc. Technological proliferation and increasing demand in commercial ... to drive the market growth.      ... The development of advanced multimodal techniques for biometric ...
    (Date:6/7/2016)...  Syngrafii Inc. and San Antonio Credit Union ... integrating Syngrafii,s patented LongPen™ eSignature "Wet" solution into ... result in greater convenience for SACU members and ... existing document workflow and compliance requirements. ... Highlights: ...
    Breaking Biology News(10 mins):